Underlying mechanisms for. and cerebrovascular damage. Saske Hoving, Nicola Russell, Sylvia Heeneman, Mat Daemen

Size: px
Start display at page:

Download "Underlying mechanisms for. and cerebrovascular damage. Saske Hoving, Nicola Russell, Sylvia Heeneman, Mat Daemen"

Transcription

1 Underlying mechanisms for radiation-induced i d d cardiovascular and cerebrovascular damage Fiona Stewart t Saske Hoving, Nicola Russell, Sylvia Heeneman, Mat Daemen

2 Radiation as an independent risk factor for cardio- and cerebro-vascular disease in cancer patients Early breast cancer: RR fatal CVD RT vs no RT; EBCT = 1.3 Testicular cancer: SIR 1.17 fatal and non-fatal CVD Hodgkin s disease: RR fatal CVD 2-7; higher risks for children RR stroke 4.3 H&N cancer patients: RR stroke Pediatric cranial RT>30 Gy: leukemia RR stroke 5.9 brain tumor RR stroke 38

3 Increased risk of stroke after radiotherapy for H&N cancer: NKI cohort (n = 367; Gy) 15 Cum mulative ris sk of stroke (%) RR of stroke 5.6 RR for FU >10 years = Time after neck irradiation (years) Dorresteijn et al JCO 2002

4 Increased risk of congestive heart failure after radiotherapy for breast cancer (40-50 Gy to IMC) Mean heart dose Chest wall/ R breast 3 Gy Chest wall/ L Breast 7 Gy IMC + R chest 11 Gy IMC+ L chest 15 Gy Chest wall/ R breast Chest wall/ L Breast IMC + R chest IMC+ L chest 1.5 Gy 5 Gy 9 Gy 13 Gy Hooning et al JNCI 2007

5 Left direct internal mammary field 6MV Right coronary artery Left anterior descending coronary artery Circumflex coronary artery Target Field arrangement Beam energy Typical dose Heart Mean dose (Gy) LAD RCA Circ Left IMC Direct anterior 6MV Co-60 Elec 10 Mev 250 kv 50 Gy in Gy in Gy in Gy in Taylor et al. IJROBP (2007)

6 Increased risk of vascular diseases in life span study of A-bomb survivors Preston et al Rad Res 2003

7 Dose response for fatal CVD after RT Schultz Hector & Trott 2007 Exces ss Relativ ve Risk * Peptic Heart ulcer disease RT Carr 2005 Breast ERRcancer 0.17 Sv RT Darby 2005, EBCT % CI 0.08; 0.26 P = * * Approximate Colon average Dose effective (Sv) dose to heart (Gy)

8 Clinical manifestations and pathogenesis of radiation induced vascular damage Endothelial cells: expression of thrombotic and inflammatory cytokines, proliferation, cell loss (days) Myocardial capillary network: obstruction microvessels, decreased d capillary density, perfusion defects, hypoxia, myocardial degeneration and fibrosis (weeks) Medium sized vessels: intimal thickening, perivascular fibrosis (weeks) Pericardium: pericarditis (early inflammatory response) (months) Myocardium: reduced d systolic function, valve defects (months) Coronary/carotid arteries: atherosclerosis, stenosis, coronary artery disease, stroke/myocardial infarct (years)

9 Radiation induced prothrombotic changes in microvessels Endothelial cell damage Increased vwf Reduceded PGI 2 Reduced ADPase Reduced d TM Inflammatory cytokines Platelet aggregation Thrombus formation Vascular occlusion Ischemic coga organ failure ue Cell detachment Exposed subendothelium

10 Microvascular damage in irradiated cancer patients: telangiectasia Irradiated human bowel Irradiated human chest wall Irradiated human rectum Irradiated rat spinal cord

11 Progression of telangiectasia in irradiated cancer patients Breast cancer Turesson & Notter 1986 Prostate cancer Wachter et al 2001 Dose response 35 fr V 90 >57% 30 fr Latency 25 fr V 90 <57% 20 fr Time from treatment (months) Time from treatment (months)

12 Microvascular damage in irradiated rat heart dex (%) Labeling ind Time from irradiation (days) Capillary density Time from irradiation (days) Reduced expression of alkaline phosphatase p and increased EC proliferation Precedes reduced capillary density and myocardial degeneration Lauk & Trott IJRB 1990

13 Heart damage in rats after local irradiation (20 Gy/1 year) Myocardial degeneration and interstitial fibrosis Perivascular fibrosis Progressive myocardial degeneration and fibrosis follows reduced capillary density J. Kruse 2002

14 Heart damage in rats after local irradiation (20 Gy/1 year) Decreased cardiac output (to 50% control) parallels focal myocardial degeneration Further reduction in CO only seen immediately before congestive heart failure Compensatory mechanisms (upregulation of cardiac β- adrenergic receptors) maintain steady state for many weeks Schultz-Hector et al. Rad Res 1992

15 Step 2 SPECT/CT and ultrasound imaging of irradiated mouse hearts heart (%) Blood volume of the 10 0 Gy 16 Gy 8 6 * weeks 20 weeks End diast tolic volume (cm 3 ) * 0 Gy 16 Gy Cardiac output (cm 3 /m min) * 0 Gy 16 Gy 22 % decrease in blood volume (p = 0.03) 03) 32 % decrease in EDV (p <0.001); 19% decrease in CO (p = 0.042) Stewart, Seemann, Visser, unpublished

16 Prospective evaluation of perfusion defects in patients after RT for left sided breast cancer FU time Wall motion abnormalities Wall motion abnormalities (months) No perfusion defects With perfusion defects 6 4/53 (7.5%) 8/20 (40%*) 12 2/39 (5.1%) 2/16 (12.5%) 24 0/14 (0%) 3/11 (27.3%*) Progressive increase in perfusion defects, most prevalent when >5% LV included in RT field Wall motion abnormalities in LV correlated with perfusion defects Marks et al. IJROBP 2005

17 Diastolic dysfunction after mediastinal RT for Hodgkin s lymphoma Heidenreich et al. AHJ 2005 High prevalence of diastolic dysfuntion in asymptomatic patients Associated with stress induced ischemia (wall motion and perfusion defects; 28% vs 11%) and worse cardiac event free survival Diastolic dysfunction probably result of microvascular thrombosis and ischemia leading to fibrosis

18 Initiation of age-related atherosclerosis Monocyte Rolling Sticking LDL Vessel lumen Transmigration Endothelial cells HDL E-selectin Adhesion molecules VCAM-1 ICAM-1 MCP-1 LDL HDL Intima Oxidized LDL Cytokines Foam cell Growth factors Metalloproteinases HDL promote cholesterol efflux Cell proliferation Matrix degradation

19 Progression of age-related atherosclerosis Libby, Nature 2002 Intima Media SMCs Normal artery ECs Adventitia Early atheroma Stabilized advanced plaque Vulnerable initial plaque Thrombosis of ruptured plaque

20 Increased IMT in carotid artery after unilateral l neck irradiation IMT differences measured using 0 Gy Duplex ultrasound Gy IMT 0.83 mm vs 1.13 mm* (FU >10 yrs: 0.68 mm vs 1.35 mm) Other prospective p studies show increased rate of progression of IMT and stenosis in irradiated carotid arteries Dorresteijn et al EJC 2005

21 Characterization of radiation damage in mid sized arteries of H&N cancer patients Russell, Hoving et al. R&O in press Resection material from patients undergoing reconstructive surgery Irradiated branch of carotid (50-70 Gy) and unirradiated donor artery (radial) from same patient RT (n = 25) Control (n = 45) Age (years) 54 ± ± 10 Smoking 26 ± ± 23 (pack years) FU (years) 4 ± 7 - Unirradiated d neck (facial) Dose (Gy) 66 ± 7 - and radial artery from other surgical patients BMI 25 ± 7 24 ± 4

22 Increased IMT after radiotherapy in neck artery of H&N cancer patients Russell, Hoving et al. R&O in press neck/facial radial Mean IMT carotid P=0.018 /radial IMT carotid P= Gy (n=45) 65 Gy (n=25) I 0 0 Gy (n=36) 65 Gy (n=18)

23 Study design: irradiation of mouse carotid arteries in ApoE-/- mice (wild type mice have very low levels of LDL and are resistant to atherosclerosis) 1.5 cm 100% 2.0 cm 8-10% % of full dose 0 <4%

24 Increased incidence of early fatty streaks in irradiated arteries of ApoE-/- mice Hoving et al IJROBP 2008 Follow-up time 0 Gy 14 Gy 1week 0/10 0/10 4 weeks 0/9 4/9 *

25 Analysis of plaques in ApoE -/- mice Initial lesion Advanced lesion 50 µm 100 µm Macrophage rich No fibrous cap Necrotic lipid core Fibrous cap

26 Increased numbers of carotid lesions after irradiation Stewart et al, AJP 2006 Hoving et al IJROBP 2008 Numbe er of lesions Total * * * * Numbe er of lesions 5 Initial 4 * * * 0 20 x 20 x 20 x 20 x 0 Gy 2 Gy 0 Gy 2 Gy M- 22 wk M- 34 wk 0 Gy 14 Gy M wk 0 Gy 8 Gy 14 Gy F- 30 wk 0 20 x 0 Gy 20 x 2 Gy 20 x 0 Gy 20 x 2 Gy M- 22 wk M- 34 wk 0 Gy 14 Gy M wk 0 Gy 8 Gy 14 Gy F- 30 wk Increased total plaque area in carotid arteries of irradiated mice Increased total plaque area in carotid arteries of irradiated mice Increased thrombotic features in plaque of irradiated arteries No out of field effects

27 Interaction between hypercholesterolemia and radiation 8 Gy / HFD (C57Bl6 mice) 8 Gy / chow Tribble et al 1999

28 Thrombotic phenotype of lesions in irradiated carotid arteries Stewart et al. AJP 2006

29 Decreased collagen content in irradiated advanced lesions Hoving et al IJROBP % Col llagen * * 0 20x0 Gy 20x2 Gy 20x0 Gy 20x2 Gy 22 wk 34 wk

30 Is it possible to inhibit the development or progression of radiation-induced i d d atherosclerosis?

31 Involvement of oxidative stress in radiation induced d athrosclerosis 8 Gy 0 Gy Two-fold lower lesion area in irradiated SOD-transgenic mice Singlet O 2 in irradiated aorta reduced in SOD-transgenics Cont SOD-TG Cont SOD-TG Tribble et al 1999

32 Intervention strategies: study design Hoving et al unpublished 25 Irradiation of carotid arteries 20 4 or 30 weeks follow up 15 Control chow 10 ASA (300 mg/kg/day) 5 NO-ASA (60 mg/kg/day) 25 Clopidogrel (20 mg/kg/day) 20 Atorvastatin (15 mg/kg/day) ohm) Amplitude (O Ohm) A mplitude (o Am ) Amplitude (Ohm) Platelet aggregation 0 * Control Clopidogrel Atorvastatin * Control ASA high 0

33 Expression of ICAM-1, VCAM-1 and TM 4 weeks after irradiation (position 0) Hoving et al unpublished 80 ICAM-1 ICAM-1/CD31 (% %) Control 14 Gy NO-ASA 14 Gy ASA high 14 Gy VCAM-1 VCAM-1/CD31 1 (%) * TM Thrombomodul lin/cd31 (%) * O -1 Average ± SEM

34 Effect of (NO-)ASA on atherosclerosis Num mber of lesion ns 8 6 Hoving et al unpublished NO-ASA reduced # lesions in unirradiated ApoE-/- mice 4 2 * Control 0 Gy NO-ASA 0 Gy ASA high 0 Gy Num mber of lesion ns 0 No reduction in plaque after RT but ASA induced d plaque stabilization ti Control NO-ASA 10 ASA high % Collagen * 0 0

35 Effect of Clopidogrel or Atorvastatin on atherosclerosis in ApoE-/- mice Hoving et al unpublished al plaque area a (mm 2 ) Tot Unirradiated Control Clopidogrel Atorvastatin 0.50 * 0.00 Tot tal plaque area a (mm 2 ) Irradiated Control Clopidogrel Atorvastatin Clopidogrel Reduced total plaque area in unirradiated mice No effect on plaque area, phenotype or collagen content in irradiated mice Atorvastatin No effect on number of lesions, plaque area or phenotype or collagen content

36 Summary Inflammatory and thrombotic changes in microvasculature precede radiation induced myocardial degeneration, fibrosis and cardiac damage Perfusion defects common in asymptomatic patients at 2 years after RT >5% LV; associated with stress induced ischemia and subsequent cardiac events Irradiation of large vessels in combination with high cholesterol initiates and potentiates atherosclerosis Lesions in irradiated d arteries more inflammatory and less stable than age related lesions Anti-platelet and anti-inflammatory inflammatory drugs less effective against radiation induced than age related atherosclerosis

Pathology of Coronary Artery Disease

Pathology of Coronary Artery Disease Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology

More information

Ischemic heart disease

Ischemic heart disease Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery

More information

Arteriosclerosis & Atherosclerosis

Arteriosclerosis & Atherosclerosis Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,

More information

Blood Vessels. Dr. Nabila Hamdi MD, PhD

Blood Vessels. Dr. Nabila Hamdi MD, PhD Blood Vessels Dr. Nabila Hamdi MD, PhD ILOs Understand the structure and function of blood vessels. Discuss the different mechanisms of blood pressure regulation. Compare and contrast the following types

More information

Dyslipidemia Endothelial dysfunction Free radicals Immunologic

Dyslipidemia Endothelial dysfunction Free radicals Immunologic ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and

More information

Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?

Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start? Objectives Acute Coronary Syndromes; The Nuts and Bolts Michael P. Gulseth, Pharm. D., BCPS Pharmacotherapy II Spring 2006 Compare and contrast pathophysiology of unstable angina (UA), non-st segment elevation

More information

Radioterapia nel trattamento del carcinoma mammario e cardiotossicità:

Radioterapia nel trattamento del carcinoma mammario e cardiotossicità: Radioterapia nel trattamento del carcinoma mammario e cardiotossicità: un problema reale, da quantificare, da evitare Bruno Meduri A.O.U. Policlinico di Modena Radioterapia nel trattamento del carcinoma

More information

Cardiovascular disease after radiation therapy

Cardiovascular disease after radiation therapy Cardiovascular disease after radiation therapy Giovanna Gagliardi Section of Radiotherapy Physics and Engineering Dept. of Medical Physics Karolinska University Hospital, Stockholm EU Scientific Seminar

More information

THE BLOOD VESSELS. Manar hajeer, MD University of Jordan Faculty of medicine, pathology department.

THE BLOOD VESSELS. Manar hajeer, MD University of Jordan Faculty of medicine, pathology department. THE BLOOD VESSELS Manar hajeer, MD University of Jordan Faculty of medicine, pathology department. Vascular pathology: 1- Narrowing or complete obstruction of vessel lumina, either progressively (e.g.,

More information

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD Week 3: Cardiovascular Disease Learning Outcomes: 1. Define the difference forms of CVD 2. Describe the various risk factors of CVD 3. Describe atherosclerosis and its stages 4. Describe the role of oxidation,

More information

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries

More information

Threshold doses and circulatory disease risks

Threshold doses and circulatory disease risks Threshold doses and circulatory disease risks Jolyon Hendry Christie Hospital Medical Physics and Engineering Manchester UK 17/10/2013 ICRP 2013 1 Threshold Dose (TD) TD 1% ICRP 41 (1984), 60 (1991), 103

More information

Assessment of plaque morphology by OCT in patients with ACS

Assessment of plaque morphology by OCT in patients with ACS Assessment of plaque morphology by OCT in patients with ACS Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Unstable plaque Intima Lipid core Plaque rupture and coronary events

More information

ATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber

ATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber ATHEROSCLEROSIS زيد ثامر جابر Zaid. Th. Jaber Objectives 1- Review the normal histological features of blood vessels walls. 2-define the atherosclerosis. 3- display the risk factors of atherosclerosis.

More information

Cardiac CT Angiography

Cardiac CT Angiography Cardiac CT Angiography Dr James Chafey, Radiologist Why do we need a better test for C.A.D? 1. CAD is the leading cause of death in the US CAD 31% Cancer 23% Stroke 7% 2. The prevalence of atherosclerosis

More information

Prevalence of Coronary Artery Disease: A Tertiary Care Hospital Based Autopsy Study

Prevalence of Coronary Artery Disease: A Tertiary Care Hospital Based Autopsy Study Article History Received: 03 Feb 2016 Revised: 05 Feb 2016 Accepted: 08 Feb 2016 *Correspondence to: Dr. Alpana Jain Senior demonstrator SMS Medical College, Jaipur, Rajasthan, INDIA. dr.alpana.jain@gmail.com

More information

Threshold doses and circulatory disease risks

Threshold doses and circulatory disease risks Threshold doses and circulatory disease risks J.H. Hendry Christie Medical Physics and Engineering, Christie Hospital, Manchester M20 4BX, UK; e-mail: jhendry2002uk@yahoo.com Abstract Tissue reactions

More information

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005 Pathology of Vulnerable Plaque Angioplasty Summit 25 TCT Asia Pacific, Seoul, April 28-3, 25 Renu Virmani, MD CVPath, A Research Service of the International Registry of Pathology Gaithersburg, MD Plaque

More information

Pathophysiology of Lipid Disorders

Pathophysiology of Lipid Disorders Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history

More information

Pathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD

Pathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD Pathophysiology of Cardiovascular System Dr. Hemn Hassan Othman, PhD hemn.othman@univsul.edu.iq What is the circulatory system? The circulatory system carries blood and dissolved substances to and from

More information

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015 Complications of Diabetes mellitus Dr Bill Young 16 March 2015 Complications of diabetes Multi-organ involvement 2 The extent of diabetes complications At diagnosis as many as 50% of patients may have

More information

HIV and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Implications

HIV and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Implications HIV and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Implications Matthew J. Feinstein, MD, MSc Assistant Professor of Medicine Northwestern University Feinberg School of Medicine Chicago,

More information

The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories

The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories Cardiac biomarkers in atherosclerosis Najma Asadi MD-APCP Ross and Colleagues in 1973: Response to Injury

More information

Can seal oil contribute to better human health?

Can seal oil contribute to better human health? Can seal oil contribute to better human health? Bjarne Østerud and Edel O. Elvevoll, Faculty of Medicine and NFH, University of Tromsø E-mail: bjarne@fagmed. Historical background Old food lore of seafood

More information

Cardiovascular diseases related to ionizing radiation: The risk of low-dose exposure (Review)

Cardiovascular diseases related to ionizing radiation: The risk of low-dose exposure (Review) INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 38: 1623-1641 OA, 2016 Cardiovascular diseases related to ionizing radiation: The risk of low-dose exposure (Review) BJORN BASELET 1,2*, CHARLOTTE ROMBOUTS 1,3*,

More information

ROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret

ROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret ROLE OF INFLAMMATION IN HYPERTENSION Dr Barasa FA Physician Cardiologist Eldoret Outline Inflammation in CVDs the evidence Basic Science in Cardiovascular inflammation: The Main players Inflammation as

More information

UNDERSTANDING ATHEROSCLEROSIS

UNDERSTANDING ATHEROSCLEROSIS UNDERSTANDING ATHEROSCLEROSIS UNDERSTANDING ATHEROSCLEROSIS ARTERIES Arteries are blood vessels that carry oxygenated blood to all the organs of the body. Arteries are made up of three important layers:

More information

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem

More information

Common Codes for ICD-10

Common Codes for ICD-10 Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified

More information

Aneurysms & a Brief Discussion on Embolism

Aneurysms & a Brief Discussion on Embolism Aneurysms & a Brief Discussion on Embolism Aneurysms, overview = congenital or acquired dilations of blood vessels or the heart True aneurysms -involve all three layers of the artery (intima, media, and

More information

Dyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram

Dyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram Dyslipidaemia Is there any new information? Dr. A.R.M. Saifuddin Ekram PhD,FACP,FCPS(Medicine) Professor(c.c.) & Head Department of Medicine Rajshahi Medical College Rajshahi-6000 New features of ATP III

More information

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers EAE Teaching Course Magnetic Resonance Imaging Competitive or Complementary? Sofia, Bulgaria, 5-7 April 2012 F.E. Rademakers Complementary? Of Course N Engl J Med 2012;366:54-63 Clinical relevance Treatment

More information

Lupus as a risk factor for cardiovascular disease

Lupus as a risk factor for cardiovascular disease Lupus as a risk factor for cardiovascular disease SØREN JACOBSEN Department Rheumatology, Rigshospitalet Søren Jacobsen Main sponsors: Gigtforeningen Novo Nordisk Fonden Rigshospitalet Disclaimer: Novo

More information

Imaging Atheroma The quest for the Vulnerable Plaque

Imaging Atheroma The quest for the Vulnerable Plaque Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing

More information

Quinn Capers, IV, MD

Quinn Capers, IV, MD Heart Attacks Mended Hearts Presentation, January, 2017 Quinn Capers, IV, MD Associate Professor of Medicine (Cardiovascular Medicine) Director, Transradial Coronary Interventions Division of Cardiovascular

More information

PATIENTS AND METHODS:

PATIENTS AND METHODS: BACKGROUND: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by erosive synovitis that involves peripheral joints and implicates an important influence in the quality

More information

ATHEROSCLEROSIS. Secondary changes are found in other coats of the vessel wall.

ATHEROSCLEROSIS. Secondary changes are found in other coats of the vessel wall. ATHEROSCLEROSIS Atherosclerosis Atherosclerosis is a disease process affecting the intima of the aorta and large and medium arteries, taking the form of focal thickening or plaques of fibrous tissue and

More information

Histopathology: Vascular pathology

Histopathology: Vascular pathology Histopathology: Vascular pathology These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about these

More information

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories

More information

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD Our laboratory focuses on the role of apolipoprotein (apo) B- containing lipoproteins in normal

More information

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure

More information

The Study of Endothelial Function in CKD and ESRD

The Study of Endothelial Function in CKD and ESRD The Study of Endothelial Function in CKD and ESRD Endothelial Diversity in the Human Body Aird WC. Circ Res 2007 Endothelial Diversity in the Human Body The endothelium should be viewed for what it is:

More information

Inflammation: Novel Target for Cardiovascular Risk Reduction

Inflammation: Novel Target for Cardiovascular Risk Reduction Inflammation: Novel Target for Cardiovascular Risk Reduction Andrew Zalewski, M.D. Thomas Jefferson University, Philadelphia GlaxoSmithKline, Philadelphia Why inflammation? Population-based studies: low

More information

PATHOPHYSIOLOGY OF ACUTE CORONARY SYNDROMES

PATHOPHYSIOLOGY OF ACUTE CORONARY SYNDROMES PATHOPHYSIOLOGY OF ACUTE CORONARY SYNDROMES Brian R. Holroyd, MD, FACEP, FRCPC Professor and Director, Division of Emergency Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton,

More information

The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the

The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the limbs and major organs. A range of important pathologies

More information

Mechanism: How ADT accelerates CVD?

Mechanism: How ADT accelerates CVD? Mechanism: How ADT accelerates CVD? Professor Bertrand Tombal, MD, PhD Cliniques universitaires Saint-Luc Université catholique de Louvain Brussels, Belgium Credentials and conflict of interests Professor

More information

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014 Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain,

More information

Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice

Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice Atherosclerosis, 2007 Chiba T, Shinozaki S, Nakazawa T, et al. Present by Sudaporn Pummoung Apolipoprotein E (apoe( apoe)

More information

Fourth Practical Pathology. Circulatory disturbances

Fourth Practical Pathology. Circulatory disturbances Fourth Practical Pathology Circulatory disturbances 12.12.2018 1 Organ: Lung (40X, low power) 1) The blood capillaries within the alveolar septa are engorged with blood 2) Pinkish proteinaceous fluid,

More information

12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2

12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2 Coronary Artery Pathophysiology ACS / AMI LeRoy E. Rabbani, MD Director, Cardiac Inpatient Services Director, Cardiac Intensive Care Unit Professor of Clinical Medicine Major Determinants of Myocardial

More information

Future Applications of Contrast Echocardiography

Future Applications of Contrast Echocardiography Future Applications of Contrast Echocardiography Jonathan R. Lindner, M.D. Knight Cardiovascular Institute Oregon Health & Science University Portland, Oregon, USA Disclosures: Investigator-initiated grant

More information

Invited Review. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases

Invited Review. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases Histol Histopathol (2000) 15: 557-571 Histology and Histopathology Cellular and Molecular Biology Invited Review Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular

More information

Pathology of Cardiovascular Interventions. Body and Disease 2011

Pathology of Cardiovascular Interventions. Body and Disease 2011 Pathology of Cardiovascular Interventions Body and Disease 2011 Coronary Artery Atherosclerosis Intervention Goals: Acute Coronary Syndromes: Treat plaque rupture and thrombosis Significant Disease: Prevent

More information

RADIATION HEART DISEASE: MANAGEMENT STRATEGIES

RADIATION HEART DISEASE: MANAGEMENT STRATEGIES RADIATION HEART DISEASE: MANAGEMENT STRATEGIES AMMAR CHAUDHARY MBChB, ABIM, FRCPC ASSOCIATE CONSULTANT CARDIOLOGIST KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTER - JEDDAH Scope of the Problem ~ 50

More information

1 Functions of endothelial cells include all the following EXCEPT. 2 Response to vascular injury is characterised by

1 Functions of endothelial cells include all the following EXCEPT. 2 Response to vascular injury is characterised by airns ase Hospital mergency epartment Part 1 FM MQs 1 Functions of endothelial cells include all the following XPT Formation of von-willebrand factor Formation of collagen and proteoglycans Formation of

More information

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life

More information

Vulnerable Plaque. Atherothrombosis

Vulnerable Plaque. Atherothrombosis Vulnerable Plaque Nuove acquisizioni sull'aterosclerosi: placca vulnerabile Marina Camera Dip. Scienze Farmacologiche, Facoltà di Farmacia, Università degli Studi di Milano & Laboratorio di Biologia Cellulare

More information

Glossary For TheFatNurse s For All Ages Series Adipocytes, also known as lipocytes and fat cells, are the cells that primarily compose adipose tissue, specialized in storing energy as fat. Apolipoprotein

More information

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,

More information

BUSINESS. Articles? Grades Midterm Review session

BUSINESS. Articles? Grades Midterm Review session BUSINESS Articles? Grades Midterm Review session REVIEW Cardiac cells Myogenic cells Properties of contractile cells CONDUCTION SYSTEM OF THE HEART Conduction pathway SA node (pacemaker) atrial depolarization

More information

Innate Immunity in Atherosclerosis

Innate Immunity in Atherosclerosis Innate Immunity in Atherosclerosis Peter Libby Brigham & Women s Hospital Harvard Medical School IAS Amsterdam May 26, 2015 ACS Stable demand angina Characteristics of Atherosclerotic Plaques Associated

More information

Lipid/Lipoprotein Structure and Metabolism (Overview)

Lipid/Lipoprotein Structure and Metabolism (Overview) Lipid/Lipoprotein Structure and Metabolism (Overview) Philip Barter President, International Atherosclerosis Society Centre for Vascular Research University of New South Wales Sydney, Australia Disclosures

More information

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology Arterial Diseases Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology Disease Spectrum Arteriosclerosis Atherosclerosis

More information

Myocardial Infarction

Myocardial Infarction Myocardial Infarction MI = heart attack Defined as necrosis of heart muscle resulting from ischemia. A very significant cause of death worldwide. of these deaths, 33% -50% die before they can reach the

More information

1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI).

1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI). 1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI). 5- cardiogenic shock (massive MIs >40% of the left ventricle)

More information

III. Results and Discussion

III. Results and Discussion III. Results and Discussion 1. Histological findings in the coronary artery Twenty-four swine had surgical treatments performed in two of the coronary arteries, LAD as well as either the LCX or RCA. A

More information

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien

More information

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Coronary Artery Imaging Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Larger array : cover scan area Detector size : spatial resolution Rotation speed : scan time Retrospective

More information

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant

More information

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology Cardiovascular Disorders Bio 375 Pathophysiology Heart Disorders Heart disease is ranked as a major cause of death in the U.S. Common heart diseases include: Congenital heart defects Hypertensive heart

More information

Depression and Subclinical Vascular Diseases in Psoriasis

Depression and Subclinical Vascular Diseases in Psoriasis Depression and Subclinical Vascular Diseases in Psoriasis Nehal N. Mehta, MD MSCE FAHA Section Chief, Inflammation and Cardiometabolic Diseases National Heart, Lung, and Blood Institute, USA Lasker Clinical

More information

ISCHEMIC HEART DISEASE IN THE CANCER PATIENT: THOMAS M. SUTER MD UNIVERSITY HOSPITAL BERN, SWITZERLAND

ISCHEMIC HEART DISEASE IN THE CANCER PATIENT: THOMAS M. SUTER MD UNIVERSITY HOSPITAL BERN, SWITZERLAND UNIVERSITÄTSKLINIK FÜR KARDIOLOGIE ZENTRUM FÜR HERZINSUFFIZIENZ KARDIO-ONKOLOGIE ISCHEMIC HEART DISEASE IN THE CANCER PATIENT: CONSIDERATIONS BEYOND CONVENTIONAL ARTERIOSCLEROSIS CARDIAC TOXICITIES ARISING

More information

The Cardiovascular System Part I: Heart Outline of class lecture After studying part I of this chapter you should be able to:

The Cardiovascular System Part I: Heart Outline of class lecture After studying part I of this chapter you should be able to: The Cardiovascular System Part I: Heart Outline of class lecture After studying part I of this chapter you should be able to: 1. Describe the functions of the heart 2. Describe the location of the heart,

More information

HDL and Arterial Wall

HDL and Arterial Wall JIFA January 31th 2014 HDL and Arterial Wall P-J TOUBOUL INSERM698 Bichat University Conflict of Interest M Ath intellectual property owner Involvement in R & D for atherosclerosis software developments

More information

Causes of death in Diabetes

Causes of death in Diabetes Rates of CV events in Diabetes patients Respiratory4.2 Cancer 7.6 Diabetes 1.3 CV disease 17.3 Causes of death in Diabetes 250 200 150 100 50 0 per 10,000 person-years 97 151 243 Framingham 5 X increase

More information

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular

More information

Plaque Imaging: What It Can Tell Us. Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD

Plaque Imaging: What It Can Tell Us. Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD Plaque Imaging: What It Can Tell Us Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD Buffalo Disclosure Information FINANCIAL DISCLOSURE: Research and consultant

More information

Non-invasive Imaging of Carotid Artery Atherosclerosis

Non-invasive Imaging of Carotid Artery Atherosclerosis Non-invasive Imaging of Carotid Artery Atherosclerosis 최연현 성균관의대삼성서울병원영상의학과 Noninvasive Techniques US with Doppler CT MRI Ultrasonography Techniques of Carotid US US Anatomy (ICA vs ECA) Gray scale and

More information

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Cottrell Memorial Lecture Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Stephen Nicholls MBBS PhD @SAHMRI_Heart Disclosures Research support: AstraZeneca,

More information

Optical Coherence Tomography for Intracoronary Imaging

Optical Coherence Tomography for Intracoronary Imaging Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland

More information

Diagnostic and Prognostic Value of Coronary Ca Score

Diagnostic and Prognostic Value of Coronary Ca Score Diagnostic and Prognostic Value of Coronary Ca Score Dr. Ghormallah Alzahrani Cardiac imaging division, Adult Cardiology department Prince Sultan Cardiac Center ( PSCC) Madina, June 2 Coronary Calcium

More information

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.

More information

THROMBOSIS. Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan

THROMBOSIS. Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan THROMBOSIS Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan NORMAL BLOOD VESSEL HISTOLOGY THROMBOSIS Pathogenesis (called Virchow's triad): 1. Endothelial*

More information

Cho et al., 2009 Journal of Cardiology (2009), 54:

Cho et al., 2009 Journal of Cardiology (2009), 54: Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal

More information

DECLARATION OF CONFLICT OF INTEREST. No conflicts of interest

DECLARATION OF CONFLICT OF INTEREST. No conflicts of interest DECLARATION OF CONFLICT OF INTEREST No conflicts of interest University Heart Centre Tübingen Angiogenic actions of platelets Meinrad Gawaz, MD, FESC Tübingen, Germany ESC 2011 Paris GPIb GPIb GPVI TxA2

More information

Introduction. Risk factors of PVD 5/8/2017

Introduction. Risk factors of PVD 5/8/2017 PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental

More information

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Greyscale IVUS studies have shown Plaque ruptures do not occur randomly

More information

In the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension

In the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial

More information

Pathophysiology of Coronary Microvascular Dysfunction

Pathophysiology of Coronary Microvascular Dysfunction Pathophysiology of Coronary Microvascular Dysfunction Cheol Woong Yu, MD, PhD Cardiology Department Division of Internal Medicine Korea University Anam Hospital. Etiologies of Chest Pain without obstructive

More information

RADIATION PROTECTION NO 158

RADIATION PROTECTION NO 158 EUROPEAN COMMISSION RADIATION PROTECTION NO 158 EU Scientific Seminar 2008 Emerging evidence for radiation induced circulatory diseases Proceedings of a scientific seminar held in Luxembourg on 25 November

More information

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG Diabetes Mellitus: Update 7 What is the unifying basis of this vascular disease? Eugene J. Barrett, MD, PhD Professor of Internal Medicine and Pediatrics Director, Diabetes Center and GCRC Health System

More information

actually rupture! Challenges to the vulnerable plaque concept

actually rupture! Challenges to the vulnerable plaque concept An Update on the Pathogenesis of the Acute Coronary Syndromes Peter Libby Brigham & Women s Hospital Harvard Medical School ADVANCES IN HEART DISEASE University of California San Francisco December 20,

More information

Observe the effects of atherosclerosis on the coronary artery lumen

Observe the effects of atherosclerosis on the coronary artery lumen Clumps and Bumps: A Look at Atherosclerosis Activity 4B Activity Description This activity features actual photomicrographs of coronary artery disease in young people aged 18 24 years. Students will observe

More information

Risk of cardiovascular disease in adolescent and adult cancer survivors

Risk of cardiovascular disease in adolescent and adult cancer survivors Risk of cardiovascular disease in adolescent and adult cancer survivors Prof. dr. Flora E. van Leeuwen Department of Epidemiology Netherlands Cancer Institute CVD risk after adolescent and adult cancer

More information

CORONARY ARTERY DISEASES

CORONARY ARTERY DISEASES CORONARY ARTERY DISEASES It has been estimated that over one third of the population eventually will die of CAD, and 20% will develop symptoms when younger than age 60 years. ANATOMY OF THE CORONARY ARTERIES

More information

Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future

Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future Cell Therapy 2014 Las Vegas, NV, USA Sulaiman Al-Hashmi, PhD Sultan Qaboos University Oman What are MSCs? Stem

More information

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC State of the Art Advances in Cardiovascular Imaging ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC Coronary Artery Disease Content Patho Physiology Imaging requirements Economical

More information

Case Study: Chris Arden. Peripheral Arterial Disease

Case Study: Chris Arden. Peripheral Arterial Disease Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she

More information